AGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human...
Day: October 12, 2021
Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
SAINT LAURENT, Quebec, Oct. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”)), a leader in...
Krystal Biotech and GeneDx Announce Collaboration to Provide No-charge Genetic Testing for Patients with Suspected Dystrophic Epidermolysis Bullosa (DEB)
The Krystal Decode DEB™ program is designed to shorten time to accurate diagnosis and facilitate the delivery of optimal carePITTSBURGH...
CinCor Pharma Raises $143 Million in Series B Financing
Funding will support continued development of CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase product candidate, for...
Coya Therapeutics Appoints Gene Mack as Chief Financial Officer
HOUSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc. (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous...
Excision BioTherapeutics Expands Management Team with Three Key Appointments
Sara Turken, J.D., as General CounselManish Anand, M.Sc., as Senior Vice President, Regulatory AffairsRobert Gunning, CPA, CGMA, as VP, ControllerSAN...
Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways
ATLANTA and WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today...
Achilles Therapeutics to join the Northern Alliance Advanced Therapy Treatment Centre consortium
- Achilles’ platform will help support the consortium to address gaps in delivering cell therapies to patients - LONDON, Oct....
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies
Technology Anticipated to Impact Cardiac Biologic Therapies, Transseptal Cardiac Procedures, and Other Interventional Catheter Based TherapiesSAN CARLOS, Calif., Oct. 12,...
Reflect Scientific Refrigeration Products Show Strong Orders
OREM, Utah, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
InnerScope Hearing Technologies (OTC: INND) Appoints Adnan Shennib as Chief Technology Officer
Industry veteran recruited to develop new hearing enhancement devices, providing consumers with alternatives to conventional hearing aidsROSEVILLE, Calif., Oct. 12,...
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the...
Emily Rollins Appointed to Science 37® Board of Directors
Emily Rollins Science 37 Appoints Emily Rollins to Board of Directors With this important addition to its Board of Directors,...
VitalHub Subsidiary S12 Solutions Reports Two Significant Contracts in September 2021
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to report that...
Venus Concept Appoints Ross J. Portaro as President of Global Sales
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of Ketoacidosis with TTP399 during Acute Insulin Withdrawal in Patients with Type 1 Diabetes
Study achieved primary endpoint of non-inferiority on measurement of key blood ketone levels Patients taking TTP399 reported no events of...
Intellia Therapeutics to Present New Preclinical Data Highlighting In Vivo and Ex Vivo Genome Editing Advances at 2021 European Society of Gene & Cell Therapy Annual Congress
First data highlighting proprietary allogeneic cell engineering platform designed to overcome immune rejection for the development of therapeutic candidates to...
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study
Cardiogenic Shock Worldwide Total Market Value Is Estimated To Be $1.25 BillionWARRINGTON, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Windtree...
Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
Results published in Otology & Neurotology, a leading journal in fieldOTO-313 was well-tolerated and demonstrated a statistically significant higher proportion...
Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit
LEXINGTON, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...
